Can a vaccine built for one Ebola virus stop another? The World Health Organization is about to find out
Kort samengevat
The WHO has recommended prioritising the Ervebo vaccine for testing in a clinical trial in the Democratic Republic of the Congo. It was not designed for the Bundibugyo species responsible for the current outbreak – which raises the question of why scientists are considering it at all
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij New Zealand Doctor.
Lees het volledige bericht ↗